Home Cart Sign in  
Chemical Structure| 1393-48-2 Chemical Structure| 1393-48-2

Structure of Thiostrepton
CAS No.: 1393-48-2

Chemical Structure| 1393-48-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Thiostrepton is a natural cyclic oligopeptide antibiotic, is a natural product of the ribosomally synthesized and post-translationally modified peptide (RiPP) class.

Synonyms: Bryamycin; Thiactin; Thiostreptin A

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Thiostrepton

CAS No. :1393-48-2
Formula : C72H85N19O18S5
M.W : 1664.89
SMILES Code : O=C(N[C@@]1(CCC(C2=NC(C(NC(C(NC(C(N)=O)=C)=O)=C)=O)=CS2)=N[C@H]1C3=CSC([C@@H](NC(C4=CSC([C@@H](NC5=O)C(O)([C@@H](C)O)C)=N4)=O)[C@H](OC(C6=NC7=C(C([C@H](C)O)=C6)C=C[C@@H](N[C@H]8C(CC)C)[C@@H]7O)=O)C)=N3)C9=NC(C(N[C@H](C(N/C(C%10=N[C@@H]5CS%10)=C/C)=O)[C@@H](C)O)=O)=CS9)[C@@H](NC(C(NC([C@@H](NC8=O)C)=O)=C)=O)C
Synonyms :
Bryamycin; Thiactin; Thiostreptin A
MDL No. :MFCD00135828

Safety of Thiostrepton

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H332
Precautionary Statements:P280

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
E. coli 70S ribosomes 0.15 µM 10 minutes To study the inhibitory effect of Thiostrepton on the GTPase activity of EF-G and EF4, the results showed that Thiostrepton significantly inhibited the GTPase activity of both EF-G and EF4. Nucleic Acids Res. 2012 Jan;40(1):360-70.
EL4 cells 0.5 µM, 1 µM, 2 µM 24 hours To investigate the effect of TST on RORγt expression in EL4 cells, results showed that TST induced ubiquitination and degradation of RORγt by promoting the binding of Itch to RORγt. Cell Mol Immunol. 2023 Nov;20(11):1352-1366.
Human monocyte-derived macrophages (hMDMs) 2.5 µM 24 hours Thiostrepton induced hMDMs to express proinflammatory cytokines TNFα and IL-1β and downregulate the M2 chemokine CCL24. Functional enrichment analysis showed that IFN/NFκB pathway, TNF-mediated pathway, oxidative-reduction process, protein polyubiquitination, and cellular response to LPS were upregulated, while DNA replication, cell cycle, and cell matrix adhesion were downregulated. Nat Commun. 2021 Feb 3;12(1):773.
Mouse bone marrow macrophages (BMMs) 2.5 µM 24 hours Thiostrepton inhibited the expression of TAM/M2-associated genes Arg1, Fizz1, Vegfa, Ym1, and Tgfb but upregulated the expression of M1-associated genes Tnf, Il1b, Cxcl2, and Nos2. Nat Commun. 2021 Feb 3;12(1):773.
Human peripheral blood mononuclear cell (PBMC)-derived macrophages 10 mM 24 hours To study the effect of Thiostrepton on macrophage polarization, results showed that Thiostrepton did not significantly promote M2 to M1 macrophage repolarization but caused slight reductions in CD86 and CD206 expression in M2 macrophages. Haematologica. 2024 Feb 1;109(2):639-645.
70S ribosomes 100 µM 3 minutes To study the effect of thiostrepton on EF-G-dependent GTP hydrolysis, results showed that thiostrepton inhibited the turnover of EF-G but did not affect single-round GTP hydrolysis. Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9586-90.
H1299 cells 5 µM 48 hours Reduced FOXM1 and PD-L1 expression, inhibited cell proliferation Adv Sci (Weinh). 2022 Oct;9(29):e2202702.
PC9 cells 5 µM 48 hours Reduced FOXM1 and PD-L1 expression, inhibited cell proliferation Adv Sci (Weinh). 2022 Oct;9(29):e2202702.
HCT-8 cells 2 µM 48 hours To test the anti-proliferative activity of Thiostrepton against CRC cells J Exp Clin Cancer Res. 2020 Jan 28;39(1):23.
HCT116 cells 2 µM 48 hours To test the anti-proliferative activity of Thiostrepton against CRC cells J Exp Clin Cancer Res. 2020 Jan 28;39(1):23.
HCT-15 cells 5 µM and 10 µM 48 hours Induced apoptosis in CRSC subpopulations and inhibited their sphere and colony formation capabilities. Cell Death Dis. 2015 Jul 2;6(7):e1801.
HT-29 cells 5 µM and 10 µM 48 hours Induced apoptosis in CRSC subpopulations and inhibited their sphere and colony formation capabilities. Cell Death Dis. 2015 Jul 2;6(7):e1801.
Panc-1 0–250 µM 48 hours To evaluate the inhibitory effect of TST on the proliferation of pancreatic cancer cells, the results showed that TST significantly reduced the growth of pancreatic cancer cells in a dose-dependent manner. Cell Death Dis. 2022 Jul 20;13(7):630.
MIA PaCa-2 0–250 µM 48 hours To evaluate the inhibitory effect of TST on the proliferation of pancreatic cancer cells, the results showed that TST significantly reduced the growth of pancreatic cancer cells in a dose-dependent manner. Cell Death Dis. 2022 Jul 20;13(7):630.
BxPC-3 0–250 µM 48 hours To evaluate the inhibitory effect of TST on the proliferation of pancreatic cancer cells, the results showed that TST significantly reduced the growth of pancreatic cancer cells in a dose-dependent manner. Cell Death Dis. 2022 Jul 20;13(7):630.
HTERT-HPNE 0–250 µM 48 hours To evaluate the inhibitory effect of TST on the proliferation of normal pancreatic ductal epithelial cells, the results showed that TST had low toxicity to normal cells. Cell Death Dis. 2022 Jul 20;13(7):630.
Human neuroglioma H4 cells 0.5, 5, 50 µM 6 hours Autophagy induction was assessed by measuring GFP-LC3 positive puncta, and 175 compounds were selected J Immunother Cancer. 2020 Mar;8(1):e000462.
Human osteosarcoma U2OS cells 50 µM 6 hours ATP release was assessed by measuring quinacrine positive dots, and Thiostrepton was identified as a potential ICD enhancer J Immunother Cancer. 2020 Mar;8(1):e000462.
Th17 cells 0.01 µM, 0.25 µM, 5 µM 72 hours To investigate the effect of TST on Th17 cell differentiation, results showed that TST significantly inhibited Th17 cell differentiation and reduced IL-17A production and RORγt expression. Cell Mol Immunol. 2023 Nov;20(11):1352-1366.
Acute myeloid leukemia (AML) cell lines 1.91 mM to 38.67 mM (ED50) 72 hours To study the cytotoxicity of Thiostrepton on leukemic cells, results showed that Thiostrepton exhibited significant cytotoxicity against AML cell lines with ED50 values ranging from 1.91 mM to 38.67 mM. Haematologica. 2024 Feb 1;109(2):639-645.
Yeast strain 6EA1 100 µM To test the inhibitory effect of Thiostrepton on yeast strain 6EA1 expressing bacterial protein L11, results showed that the strain was sensitive to Thiostrepton with an IC50 of approximately 100 µM. Nucleic Acids Res. 2007;35(21):7109-17.
Pulmonary fibroblasts 10 µM Inhibition of FOXM1 expression significantly reduced the expression of α-SMA and COL1A1 and impaired the migration ability of pulmonary fibroblasts. Stem Cell Res Ther. 2024 Sep 18;15(1):309.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice B16F10 melanoma model Intraperitoneal or subcutaneous injection 150 or 300 mg/kg (intraperitoneal injection), 20 mg/kg (subcutaneous injection) Administered on day 6 and day 12 Thiostrepton significantly suppressed tumor growth and showed additive effects with TA99. Flow cytometry analysis revealed elevated levels of macrophages and monocytes in tumors from mice treated with thiostrepton or thiostrepton plus TA99, with upregulated expression of iNOS and CD86 and downregulated expression of Arg1 in TAMs. Nat Commun. 2021 Feb 3;12(1):773.
BALB/c Nude mice H1299 and PC9 xenograft model Intraperitoneal injection 17 mg/kg Every 2 days for 9 days Significantly downregulated PD-L1 expression and reduced tumor volume Adv Sci (Weinh). 2022 Oct;9(29):e2202702.
BALB/c Nude mice Subcutaneous tumour model Intraperitoneal injection 17 mg/kg Three times a week for 3 weeks To evaluate the inhibitory effect of TST on the growth of subcutaneous tumours, the results showed that TST significantly inhibited tumour growth, and Fer-1 reversed this effect. Cell Death Dis. 2022 Jul 20;13(7):630.
Mice DSS-induced colitis model Intraperitoneal injection 20 mg/kg Every other day, for 7 days To investigate the therapeutic effect of TST on DSS-induced colitis, results showed that TST significantly alleviated colitis symptoms and controlled colonic inflammation by modulating dysbiosis. Cell Mol Immunol. 2023 Nov;20(11):1352-1366.
C57BL/6 mice MCA205 or TC-1 tumor model Intraperitoneal injection 200 mg/kg Once daily 1 day before, on, and 1 day after chemotherapy, then 40 mg/kg three times per week Thiostrepton enhanced the anticancer activity of oxaliplatin, further diminishing tumor size and extending the survival of the animals J Immunother Cancer. 2020 Mar;8(1):e000462.
Mice BLM-induced pulmonary fibrosis models Intraperitoneal injection 30 mg/kg Every other day for 2 weeks Inhibition of FOXM1 expression significantly reduced pulmonary fibrosis, decreased collagen deposition, and lowered the expression of fibrotic markers such as α-SMA and COL1A1. Stem Cell Res Ther. 2024 Sep 18;15(1):309.
Nude mice CRC xenograft model Intraperitoneal injection 500 mg/kg/day Every three days for 21 days To evaluate the anti-tumor effect of Thiostrepton on CRC xenograft model J Exp Clin Cancer Res. 2020 Jan 28;39(1):23.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.60mL

0.12mL

0.06mL

3.00mL

0.60mL

0.30mL

6.01mL

1.20mL

0.60mL

References

 

Historical Records

Categories